Literature DB >> 19836152

Postoperative seroma formation after intraoperative radiotherapy using low-kilovoltage X-rays given during breast-conserving surgery.

Uta Kraus-Tiefenbacher1, Grit Welzel, Joachim Brade, Brigitte Hermann, Kerstin Siebenlist, Klaus S Wasser, Frank S Schneider, Marc Sütterlin, Frederik Wenz.   

Abstract

PURPOSE: To determine the frequency and volume of seroma after breast-conserving surgery (BCS) with or without intraoperative radiotherapy (IORT). METHODS AND MATERIALS: Seventy-one patients with 73 breast cancers (IORT group) treated with IORT (20 Gy Intrabeam) as a boost during BCS were compared with 86 patients with 88 breast tumors (NO-IORT group) treated without IORT. Clinical examination and measurement of seroma volume on treatment-planning CT (CT-seroma) was done at median interval of 35 days after BCS.
RESULTS: Seroma were found on palpation in 37 patients (23%) and on CT in 105 patients (65%; median volume, 26.3 mL). Interval between BCS and CT was significantly shorter in patients with palpable seroma (median, 33 days) or CT-seroma (33 days) compared with those with no palpable seroma (36.5 days; p = 0.027) or CT-seroma (52 days, p < 0.001). The rate of palpable seroma was not different (IORT n = 17, 23%; NO-IORT n = 20, 23%; p = 0.933), whereas fewer patients required puncture in the IORT group [3 (4%) vs. 10 (11%)]. In contrast, more patients showed CT-seroma after IORT (IORT n = 59, 81%; NO-IORT n = 46, 52%; p < 0.001). The interval between BCS and CT was significantly shorter in patients with IORT as compared with the NO-IORT patients (median, 33 days vs. 41.5 days; p = 0.036).
CONCLUSION: Intraoperative radiotherapy with low-kilovoltage X-rays during BCS is not associated with an increased rate of palpable seroma or seroma requiring treatment. The rate of seroma formation on CT was higher after IORT compared with the NO-IORT group, which might be because of the shorter interval between BCS and CT. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19836152     DOI: 10.1016/j.ijrobp.2009.06.008

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

Review 1.  Research opportunities in intraoperative radiation therapy: the next decade 2013-2023.

Authors:  F A Calvo; C V Sole; M E González; E D Tangco; J López-Tarjuelo; I Koubychine; J A Santos; J Pascau; R Herranz; C Ferrer
Journal:  Clin Transl Oncol       Date:  2013-03-05       Impact factor: 3.405

2.  TGF-β1 Is Present at High Levels in Wound Fluid from Breast Cancer Patients Immediately Post-Surgery, and Is Not Increased by Intraoperative Radiation Therapy (IORT).

Authors:  Sandra D Scherer; Jochen Bauer; Anja Schmaus; Christian Neumaier; Carsten Herskind; Marlon R Veldwijk; Frederik Wenz; Jonathan P Sleeman
Journal:  PLoS One       Date:  2016-09-02       Impact factor: 3.240

3.  In vivo dosimetry and acute toxicity in breast cancer patients undergoing intraoperative radiotherapy as boost.

Authors:  Jason Joon Bock Lee; Jinhyun Choi; Sung Gwe Ahn; Joon Jeong; Ik Jae Lee; Kwangwoo Park; Kangpyo Kim; Jun Won Kim
Journal:  Radiat Oncol J       Date:  2017-06-30

4.  Acute Toxicity and Early Oncological Outcomes After Intraoperative Electron Radiotherapy (IOERT) as Boost Followed by Whole Breast Irradiation in 157 Early Stage Breast Cancer Patients-First Clinical Results From a Single Center.

Authors:  Laila König; Kristin Lang; Jörg Heil; Michael Golatta; Gerald Major; David Krug; Juliane Hörner-Rieber; Matthias F Häfner; Stefan A Koerber; Semi Harrabi; Tilman Bostel; Jürgen Debus; Matthias Uhl
Journal:  Front Oncol       Date:  2019-05-21       Impact factor: 5.738

Review 5.  Review of Current Accepted Practices in Identification of the Breast Lumpectomy Tumor Bed.

Authors:  Pascal Acree; Amee Kapadia; Ronak Mahatme; Lucia Zhang; Darsh Patel; Charlie Almoney; Geonwoo Park; Morgan Kofsky; Shababa Matin; Mehran Habibi
Journal:  Adv Radiat Oncol       Date:  2022-01-27

6.  Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer-better for patients, better for healthcare systems.

Authors:  Jayant Sharad Vaidya; Uma Jayant Vaidya; Michael Baum; Max Kishor Bulsara; David Joseph; Jeffrey S Tobias
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

7.  Clinical aspects of intraoperative radiotherapy in early breast cancer: short-term complications after IORT in women treated with low energy x-rays.

Authors:  Benjamin Tuschy; Sebastian Berlit; Simone Romero; Elena Sperk; Frederik Wenz; Sven Kehl; Marc Sütterlin
Journal:  Radiat Oncol       Date:  2013-04-22       Impact factor: 3.481

8.  Evaluation of Partial Breast Reirradiation with Intraoperative Radiotherapy after Prior Thoracic Radiation: A Single-Institution Report of Outcomes and Toxicity.

Authors:  Christine Chin; Priya Jadeja; Bret Taback; David P Horowitz; Sheldon M Feldman; Richard Ha; Eileen P Connolly
Journal:  Front Oncol       Date:  2017-08-28       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.